SEC Form 3 · accession 0001673870-16-000003
TETRALOGIC PHARMACEUTICALS Corp · TLOG
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Patrick Hutchison
Officer — CFO & Treasurer
Period of report
Apr 30, 2016
Accepted (ET)
May 9, 2016 · 2:40 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001361248
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 7,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Purchase)F1 | $7.72 | holding | — | — | — | — | Feb 24, 2024 | Common Stock | 25,000 | — | D |
| Stock Option (Right to Purchase)F2 | $4.51 | holding | — | — | — | — | Mar 18, 2025 | Common Stock | 11,500 | — | D |
Explanation of responses
- F113,530 option shares are currently exercisable. The option shares vest and become exercisable over a four-year period that commenced on February 24, 2014. Twenty-five percent (25%) of the option shares vested and became exercisable on February 24, 2015. The remainder vest monthly, beginning on March 24, 2015, at a rate of 520 shares per month for thirty-five (35) months following March 24,2015 and a rate of 550 shares in the thirty-sixth month.
- F23,120 option shares are currently exercisable. The option shares vest and become exercisable over a four-year period that commenced on April 18, 2015. The option shares vest monthly at a rate of 240 shares per month for forty-seven (47) months following April 18, 2015 and a rate of 220 shares in the forty-eighth month.